InvestorsHub Logo
Followers 19
Posts 1397
Boards Moderated 0
Alias Born 05/16/2018

Re: Rapture2020 post# 43373

Sunday, 05/20/2018 8:09:52 PM

Sunday, May 20, 2018 8:09:52 PM

Post# of 50157
You don't do this without the world taking interest!

The GGPO’s update was based on its evaluation of published data on treatment with CHEMOSAT as a loco-regional treatment for melanoma liver metastases.  Following this evaluation, and after soliciting additional feedback from the oncology community in Germany, treatment with CHEMOSAT was classified with Evidence Level 1B, indicating the second highest level of evidence. Treatment with CHEMOSAT is the sole therapy classified with this top designation. Other loco-regional therapies previously included in the guidelines have been designated with Evidence Level 4, indicating an absence of clinical trial supporting evidence.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News